1. Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab;Abbas;EJNMMI Res.,2011
2. 223Ra levels fed in the 223Fr β decay;Abdul-Hadi;Phys. Rev. C,1993
3. Bayer, 2015. Safety and tolerability of BAY1862864 injection in subjects with relapsed or refractory CD22-positive non-Hodgkin’s lymphoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). [cited 2016 Mar 17]. Available from: 〈https://www.clinicaltrials.gov/ct2/show/NCT02581878〉 NLM identifier: NCT02581878.
4. Bayer, 2018. First-in-human study of BAY2287411 injection, a Thorium-227 labeled antibody-chelator conjugate, in patients with tumors known to express mesothelin. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). [cited 2018 Sep 14]. Available from: 〈https://www.clinicaltrials.gov/ct2/show/NCT03507452〉 NLM identifier: NCT03507452.
5. XCOM: Photon Cross Section Database;Berger,2010